Mark L. Berch

Array ( [id] => 7691407 [patent_doc_number] => 20070232626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Purine Derivatives as A3 and A1 Adenosine Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/574779 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24771 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232626.pdf [firstpage_image] =>[orig_patent_app_number] => 11574779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348887 [patent_doc_number] => 07495003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => '8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/218057 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7802 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495003.pdf [firstpage_image] =>[orig_patent_app_number] => 11218057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046568 [patent_doc_number] => 20070265242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Novel Carbapenem Compound' [patent_app_type] => utility [patent_app_number] => 11/661662 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23474 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265242.pdf [firstpage_image] =>[orig_patent_app_number] => 11661662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348886 [patent_doc_number] => 07495002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => '3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/218056 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10256 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495002.pdf [firstpage_image] =>[orig_patent_app_number] => 11218056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829163 [patent_doc_number] => 20060063787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Condensed imidazole derivatives' [patent_app_type] => utility [patent_app_number] => 11/212407 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90834 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063787.pdf [firstpage_image] =>[orig_patent_app_number] => 11212407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585598 [patent_doc_number] => 07446194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Preparation of penicillin procaine' [patent_app_type] => utility [patent_app_number] => 11/201286 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446194.pdf [firstpage_image] =>[orig_patent_app_number] => 11201286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543410 [patent_doc_number] => 08318701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Phosphonate analogs of HIV inhibitor compounds' [patent_app_type] => utility [patent_app_number] => 11/658419 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46580 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11658419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391143 [patent_doc_number] => 20090208456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Imidazo[4,5-d]pyrimidines, their uses and methods of preparation' [patent_app_type] => utility [patent_app_number] => 11/658625 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36197 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208456.pdf [firstpage_image] =>[orig_patent_app_number] => 11658625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149694 [patent_doc_number] => 20070049754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Phosphonate analogs of HIV inhibitor compounds' [patent_app_type] => utility [patent_app_number] => 11/190225 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46888 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049754.pdf [firstpage_image] =>[orig_patent_app_number] => 11190225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92545 [patent_doc_number] => 07737273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Process for acyclic phosphonate nucleotide analogs' [patent_app_type] => utility [patent_app_number] => 11/572054 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2464 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737273.pdf [firstpage_image] =>[orig_patent_app_number] => 11572054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32856 [patent_doc_number] => 07790730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Imidazo[4,5-d]pyrimidines, their uses and methods of preparation' [patent_app_type] => utility [patent_app_number] => 11/190751 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36240 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790730.pdf [firstpage_image] =>[orig_patent_app_number] => 11190751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225135 [patent_doc_number] => 20050261316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'A2B Adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/189202 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31464 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261316.pdf [firstpage_image] =>[orig_patent_app_number] => 11189202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334401 [patent_doc_number] => 07507813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Amorphous cefuroxime axetil and preparation process therefore' [patent_app_type] => utility [patent_app_number] => 11/187555 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6587 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507813.pdf [firstpage_image] =>[orig_patent_app_number] => 11187555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931970 [patent_doc_number] => 20050283005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'PNA monomer and precursor' [patent_app_type] => utility [patent_app_number] => 11/183034 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21973 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0283/20050283005.pdf [firstpage_image] =>[orig_patent_app_number] => 11183034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738444 [patent_doc_number] => 20060008835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'PNA monomer and precursor' [patent_app_type] => utility [patent_app_number] => 11/182672 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21956 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008835.pdf [firstpage_image] =>[orig_patent_app_number] => 11182672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688974 [patent_doc_number] => 20060287289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates' [patent_app_type] => utility [patent_app_number] => 11/177640 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18593 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287289.pdf [firstpage_image] =>[orig_patent_app_number] => 11177640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821086 [patent_doc_number] => 20060025399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Crystalline anhydrous cefdinir and crystalline cefdinir hydrates' [patent_app_type] => utility [patent_app_number] => 11/177202 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18456 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 65 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025399.pdf [firstpage_image] =>[orig_patent_app_number] => 11177202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 74729 [patent_doc_number] => 07750153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Process for the preparation of didanosine using novel intermediates' [patent_app_type] => utility [patent_app_number] => 11/570358 [patent_app_country] => US [patent_app_date] => 2005-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1987 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750153.pdf [firstpage_image] =>[orig_patent_app_number] => 11570358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950130 [patent_doc_number] => 20080306256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Salts in the Preparation of Cephalosporin Antibiodies' [patent_app_type] => utility [patent_app_number] => 11/631595 [patent_app_country] => US [patent_app_date] => 2005-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4777 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306256.pdf [firstpage_image] =>[orig_patent_app_number] => 11631595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881462 [patent_doc_number] => 20060030545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Anti-proliferative compounds, compositions, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/170247 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35033 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030545.pdf [firstpage_image] =>[orig_patent_app_number] => 11170247 [rel_patent_id] =>[rel_patent_doc_number] =>)